Search Results 671-680 of 16023 for pharmacogenetics

1. Study Evaluating the Prevalence of the KIT D816V Mutation in Peripheral Blood of Patients with Evidence of Systemic Mast Cell Activation (MCA) - Mayo Clinic

   The primary objective of this study is to determine the prevalence of KIT D816V mutation in peripheral blood (PB) of patients with evidence of systemic Mast ...

2. A Study to Evaluate the Development of Patient Derived Xenografts in Patients With Breast Cancer - Mayo Clinic

   About this study. Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer.

3. Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared With CIS and GEM Alone in HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma - Mayo Clinic

   The study was conducted to assess the safety and tolerability of (1) polyethylene glycol (PEG) PEGylated Recombinant Human Hyaluronidase (PEGPH20) in ...

4. Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects - Mayo Clinic

   This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate cancer (mCRPC).

5. A Study Evaluating Fecal DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease - Mayo Clinic

   About this study. Cells with increased oncogene activity adopt a secretory phenotype. For example, increased levels of c-Src not only inhibit ...

6. A Study to Test How Muscle Tissue Differs Between People - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. Longitudinal Lung Health Study - Mayo Clinic

   This will be investigated through a collaboration with the Wortman Lung Cancer Foundation and ongoing 5 and 10 K races associated with the Foundation. The early ...

8. A Study to Evaluate the Effectiveness and Safety of BG00011 in Participants with Idiopathic Pulmonary Fibrosis (SPIRIT) - Mayo Clinic

   The primary purpose of this study is to evaluate the effectiveness of BG00011 compared with placebo in participants with Idiopathic Pulmonary Fibrosis (IPF).

9. Stomach Cancer Clinical Trials

   A Phase Ib/II, open label, multi-center, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of ...

10. Infigratinib (oral route) - Mayo Clinic

    Infigratinib is used to treat cholangiocarcinoma (bile duct cancer) that has spread or cannot be removed by surgery. It is used in patients who have already ...